Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Cardiology
What is a reasonable duration of therapy post-operatively for CCB or nitrate use in patients who have undergone CABG with radial artery bypass graft?
Related Questions
When differentiating and treating patients with shock (distributive/cardiogenic), how reliable would you consider the noninvasive clinical platform (EV1000) when derived from peripheral arterial lines?
What is your approach to evaluating a patient with a suspected myocardial contusion?
Should low-intensity statins be favored to minimize the risk of diabetes onset while still offering cardiovascular benefit for patients with prediabetes where a statin is indicated?
How do you counsel patients who develop DVT or atrial fibrillation requiring anticoagulation when being treated with lecanemab or donanemab?
Are there any ongoing clinical trials related to endothelial dysfunction and accelerated or premature CAD that patients might be able to enroll in nationwide?
How do you choose between spironolactone and finerenone for patients with proteinuric diabetic kidney disease and heart failure?
In patients with Tetralogy of Fallot and an indication for primary prevention ICD (NSVT, induced VT during EPS, or Low LVEF), should pulmonary valve interventions be offered PRIOR to ICD to assess if improvement in VT burden/EF?
What patient characteristics prompt you to prescribe vericiguat for patients with heart failure with reduced ejection fraction who are already on standard therapy?
In a patient with psoriatic arthritis and recurrent pericarditis, would you combine abatacept or other biologics with rilonacept?
Should all kidney transplant patients be started on statin therapy post operatively given their increased risk of CVD?
